StatOrigin open statistical archive
Industries Indicators Regions Rankings Compare Sources

Cell and gene therapy venture capital and public funding deal count

Number of venture capital and public funding transactions for cell and gene therapies in a given year.

Unit Count Industry Pharmaceuticals

Cite & reuse Get this data as JSON
Records
4
Regions
1
Period
2021–2023
Sources
1
Verification 4 verified data points Updated 15 Sep 2026 Last verified 15 Sep 2026 Next update Sources typically refresh annually

The chart

Over time

Global over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.

Cell and gene therapy venture capital and public funding deal count

Global, 2021 to 2023

3 observations · 2021 to 2023
Cell and gene therapy venture capital and public funding deal countCell and gene therapy venture capital and public funding deal count. 3 observations from 2021 to 2023, ranging from 96 to 127. Latest value 96 (2023). 0 30 60 90 120 150 2021 2022 2023 127 96
Cell and gene therapy venture capital and public funding deal countCell and gene therapy venture capital and public funding deal count. 3 observations from 2021 to 2023, ranging from 96 to 127. Latest value 96 (2023). 0 50 100 150 2021 2022 2023 127 96
Cell and gene therapy venture capital and public funding deal countCell and gene therapy venture capital and public funding deal count. 3 observations from 2021 to 2023, ranging from 96 to 127. Latest value 96 (2023). 0 50 100 150 2021 2022 2023 127 96
View the underlying data
Cell and gene therapy venture capital and public funding deal count
Period Type Value
2021 Actual 127
2022 Actual 97
2023 Actual 96
Source: IQVIA · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable. 

<iframe src="https://statorigin.org/embed/pharmaceuticals--cell-and-gene-therapy-venture-capital-and-public-funding-deal-count--trend" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Cell and gene therapy venture capital and public funding deal count" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/cell-and-gene-therapy-venture-capital-and-public-funding-deal-count">Cell and gene therapy venture capital and public funding deal count</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Every record

All records

4 records · 1 region · 2021–2023

Download CSV JSON series
Cell and gene therapy venture capital and public funding deal count: every record, grouped by region, newest first.
Period Value Source Type
Global 4 records
2023 100 IQVIA · 31 Dec 2023 estimate
2023 96 IQVIA · 31 Dec 2023 actual
2022 97 IQVIA · 31 Dec 2022 actual
2021 127 IQVIA · 31 Dec 2021 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios IQVIA — 4

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Cell and gene therapy venture capital and public funding deal count. Retrieved from https://statorigin.org/indicators/cell-and-gene-therapy-venture-capital-and-public-funding-deal-count

Download CSV Get this data as JSON Compare with… API docs